Researchers conducted a randomized study of 240 veterans. They evaluated patients 12 months after therapy.
Here are five quick notes:
1. Both treatments had similar outcomes concerning pain interference with activities.
2. Opioids and non-opioids had similar overall adverse symptoms.
4. Non-opioid medication had slightly better pain intensity and medication-related adverse symptoms.
5. The study is the first to evaluate long-term opioid therapy’s effectiveness, according to the study researchers.
More articles on quality and infection control:
Rising surgical demand, increase in HAIs driving sepsis therapeutics market: 4 highlights
Theranos paying Arizona residents $4.65M, won’t operate lab for two years: 4 key notes
HAI control market to surpass $82.9B by 2020 at 8.5% CAGR: 5 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.